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ABSTRACT  
 
We have carried out a study on the behaviour pattern of implanted allografts initially 
stored in perfect conditions (aseptically processed, culture-negative and stored at            
–80 °C) but which presented positive cultures at the implantation stage. There is no 
information available on how to deal with this type of situation, so our aim was to set 
guidelines on the course of action which would be required in such a case. This was a 
retrospective study of 112 patients who underwent a spinal arthrodesis and in whom a 
total of 189 allograft pieces were used. All previous bone and blood cultures and tests 
for hepatitis B and C, syphilis and HIV (via PCR techniques) were negative. The 
allografts were stored by freezing them at –80 °C. A sample of the allograft was taken 
for culture in the operating theatre just before its implantation in all cases. The results of 
the cultures were obtained 3–5 days after the operation. There were 22 allografts with 
positive culture results (12%) after implantation. These allografts were implanted in 16 
patients (14%). Cultures were positive for staphylococci coagulase negative (ECN) in 
10 grafts (46%), Pseudomonas stutzeri in two grafts (9%), Corynebacterium jeikeium in 
two grafts (9%), staphylococci coagulase positive in two grafts (9%) and for each of the 
following organisms in one case each (4%): Corynebacterium spp., Actinomyces 
odontolyticus, Streptococcus mitis, Peptostrep-tococcus spp., Rhodococcus equi and 
Bacillus spp. No clinical infection was seen in any of these patients. Positive cultures 
could be caused by non-detected contamination at harvesting, storing or during 
manipulation before implantation. The lack of clinical signs of infection during the 
follow-up of our patients may indicate that no specific treatment different from our 
antibiotic protocol is required in the case of positive culture results of a graft piece after 
implantation. 
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 INTRODUCTION 
  
Although autografts, which are usually taken from the iliac crest, are still considered to 
be the gold standard, bone allografts are being used increasingly often for long spinal 
fusions. There is always a potential risk of disease or infection transmission from the 
donor to the recipient with the use of allografts [8, 10, 19, 20], though since 1988 only 
eight cases of bone-transplantation-associated HIV infection have been reported and 
bacterial allograft infection is almost negligible (4–5%) [2, 12, 19, 21]. However, we 
could find no previous cases reports on positive cultures detected after graft 
implantation even though all the bank cultures were initially negative. There is therefore 
a lack of information as to the course of action to be taken in these circumstances. 
 
The aim of this paper is to report the rate of contamination of allografts which were in 
supposed perfect condition before their implantation, and to analyse its possible clinical 
repercussions. 
 
 
MATERIALS AND METHODS 
 
Between January 1995 and December 2000, 112 patients operated on at our Spinal 
Surgery Division received frozen cancellous bone allografts associated with surgical 
bed autograft as bone augmentation in long spinal arthrodesis. Surgical time was 
between 3 and 5 h in all cases. Grafts were taken from the freezer half an hour before 
implantation and were always processed in sterile conditions. 
 
We followed the EAMST international bone bank screening procedures for all donors 
[7]. Most allografts in our tissue bank were obtained from donor cadavers (that were 
also organ donors) in an operating room by using routine sterile techniques. Some 
femoral heads were collected from patients undergoing a hip replacement. A sample of 
bone for culture was obtained from all tissues of cadavers and patients before storage [1, 
14, 16]. Cultures of blood and tests for hepatitis B and C, syphilis and HIV (via PCR 
techniques) were also carried out. The allografts were stored by freezing to –80°C in an 
electrical freezer equipped with an alarm to ensure that tissues were kept frozen until 
needed. The grafts were kept in three closed sterile plastic bags. No secondary 
sterilization methods were used [11, 17]. We store the grafts for a maximum of 5 years 
although they are usually used in the first year after extraction. For long spinal 
arthrodesis we used morsellized cancellous bone allografts. 
 
A graft sample was obtained in each case for culture in the operation room just before 
implantation into the patient. Previous studies carried out by us showed that this is the 
most reliable method for cultures [14]. Previous to the implantation and taking the 
sample for the culture, the graft was washed with 3l of sterile physiological fluid. We 
used the same culture methods for all samples. The sample was collected in a sterile 
container. Four millilitres of trypticase soy broth (TSB) were added and shaken with a 
vortex. This was used to inoculate a blood agar plate, a chocolate blood agar plate and a 
thioglycollate broth. The blood agar and chocolate blood agar plates were incubated at 
35 °C in the presence of 10% CO2. The thioglycollate broth and the TSB with specimen 
were incubated at 35 °C. The cultures were observed every day for 5 days. The same 
method of culturing allografts was used during the recovery and processing phases and 
when the allografts were opened in the operating room for clinical implantation. 
If there was no growth on the plates, in the thioglycollate broth or in TSB the sample 
was considered negative at 5 days. When some bacterial growth was observed on the 
plates then the growth was considered as important, and if there was no growth on the 
plates but some in the thioglycollate broth or in TSB, the growth was considered as 
poor. Any bacterial growth in any medium was cause for the tissue to be refused for 
banking. Differentiation between poor and important growth concerns the bacterial 
behaviour not the amount of contamination. 
 
We reviewed 112 patients who underwent a spinal arthrodesis in which a total of 189 
allograft pieces were used. The grafts were 72 femoral heads, 62 tibial plateaux, 54 
femoral condyles and one calcaneus. 
 
Long posterior fusions were performed for deformities such as scoliosis, degenerative 
disorders or fractures. We excluded patients with oncological disease or vertebral 
infection. Our own universal fixation system was used including rods, pedicle screws, 
sublaminar wires and hooks, depending on the operation [3]. 
 
All patients received the prophylactic antibiotic protocol recommended by the Clinical 
Infections Committee of our hospital. This protocol consisted of intravenous cefazolin 1 
g/day 30 min before surgery, every 3 h during surgery and 8 h after finishing the 
operation. Clindamicin 600 mg/8 h and gentamicin 1.7 mg/kg per day were used if 
cefazolin was contraindicated. 
 
In those cases in which the postoperative culture was positive, patients received the 
regimen we currently use for massive (structured) bone allografts: oral administration of 
cefadroxile 500 mg/ 12 h for 3 weeks. None of our patients was allergic to penicillin. 
This is an empiric antibiotic protocol and, despite the fact that we have no evidence of 
its efficacy, is the recommended protocol of our hospital’s Clinical Infections 
Committee. 
 
Routine wound and temperature controls were done until the patient was discharged and 
in subsequent clinical revisions. The presence or absence of signs or symptoms of 
infection was assessed by clinical and laboratory controls. 
 
 
RESULTS 
 
From the 189 allografts used (126 from cadaver donors and 63 from live donors) we had 
22 allografts with positive culture (12%) after implantation (14 from cadaver donors 
and 8 from live donors). These allografts were implanted in 16 patients with an average 
age of 26 years (range 10–70 years). Cultures were positives for staphylococci 
coagulase negative (ECN) in 10 grafts (46%), Pseudo-monas stutzeri in two grafts (9%), 
Corynebacterium jeikeium in other two grafts (9%), staphylococci coagulase positive in 
two grafts (9%) and for Corynebacterium spp., Actinomyces odontolyticus, 
Streptococcus mitis, Peptostreptococcus spp., Rhodococcus equi and Bacillus spp. in 
graft each (4%). We found important bacterial growth in three cases (13%) and in 18 
cases (85%) growth was classified as poor (Table 1). Using our prophylactic antibiotic 
protocol with an average follow-up of 38.6 months (range 6–60 months), no clinical 
infection occurred in any of these patients. 
 
DISCUSSION 
 
The first bone banks appeared in the 1940s but it is thanks to the long series published 
by Malinin (1976) and Mankin (1983) that the use of human allografts became a 
universal practice [18]. 
 
More than 4,000 bone extractions are performed in Spain every year, from both live and 
cadaver donors. In the year 2000, a total of 60 bone banks were registered. The National 
Transplantation Organization (ONT) takes care of the coordination of the bone banks 
and gives them all directives for the correct extraction, storage, distribution and 
implantation policy. The ONT states that grafts should be obtained from live or dead 
donors in which AIDS, viral hepatitis C, viral hepatitis B and tumoral disease have been 
excluded. Grafts should be taken in sterile conditions and immediately stored at –80°C. 
Cultures of all extracted pieces should be taken before storage, and in every case in 
which the culture or the blood test is positive, the piece should be discarded. When all 
cultures are proved to be negative, the piece is stored in a new freezer ready for its use. 
Pieces can be stored for a maximum of 5 years; in this series none of the grafts had been 
stored for longer than a year. All manipulations should be done in sterile conditions. 
 
Although autografts are still the gold standard, bone allografts are being used 
progressively and are increasingly necessary for spinal arthrodesis [8, 10, 19, 21]. The 
use of autograft bone is not without complications or problems because of harvesting 
and donor site morbidity. Autograft harvesting also adds operating time and additional 
blood loss [10]. The advantages of allografts are their unlimited quantity, the time 
saving during surgery and the avoidance of donor site morbidity [8]. Several studies 
have shown that the risks are acceptable and results similar to those obtained with 
autografts [8, 10, 14, 15, 19, 21]. Bioactive ceramics may also be considered a good 
alternative when doing a posterior fusion, with no risk of transmitting disease. We have 
no experience with their use. 
 
The transmission of disease or infection from the donor to the recipient is always a risk 
with the use of allografts, but the prevalence is low [13, 20] – lower than the risk of 
transmission through transplantation of organs. Since 1988, eight cases of bone-
transplantation-associated HIV infection have been reported [12]. Gamma irradiation of 
allografts is not effective in HIV inactivation at the levels currently used. Thus, good 
screening procedures are the most effective means for providing the safest possible 
allografts [17]. No viral transmission has been registered in our bone bank since its 
creation in 1986. The incidence of bacterial infection is higher with the use of massive 
(structured) bone allografts than with cancellous bone allografts [2]. Tomford et al. [19] 
found an incidence of infection related to the use of allografts of 5% in patients having 
treatment for bone tumours and 4% in those who had revision of a hip arthroplasty. 
These rates of infection were not substantially different from those that have been 
reported in similar series in which large allografts or sterilized prosthetic devices were 
used. The causes of infection were difficult to determine, but contamination of the 
allograft was probably not a factor in most patients [19]. In March 2002, the Centers for 
Disease Control had received 26 reports of bacterial infections associated with 
musculoskeletal tissue allografts, 13 infected with Clostridium spp., including one death 
[4]. 
 
We can try to avoid infection or diminish its incidence by careful donor selection and 
the application of routine sterile techniques with bacterial cultures at extraction, storage 
and implantation of the allografts. But what should be done when a culture from an 
implanted allograft (with all extraction and storage cultures being negative) is positive? 
Although we always make routine cultures just before implantation, the results are not 
available for 5 days. If the culture is positive should the graft be removed? 
 
In the course of the present study we have reviewed more than 50 papers on general 
bone banking or allograft policy and management, and about the use of bone allografts 
in spinal surgery. We have not found any data concerning the topic of our study, either 
in these papers or in the authoritative books by Friedlander et al. [9], the EAMST 
(European Association of Musculo-Skeletal Transplantation) [7] and Czitrom and 
Winkler [5]. These books study all basic sciences and their clinical application related to 
bone allografts. Furthermore, behind the one by the EAMST are the works and 
statements of a whole scientific society specifically dedicated to the study of 
musculoskeletal tissue transplantation. Therefore, the experience that we are reporting 
now would be useful to improve knowledge about possible problems occurring in bone 
transplantation and their treatment. 
 
As an explanation of the satisfactory behaviour of our contaminated grafts, the poor 
amount of growth and the type of bacteria found in most of our positive cultures could 
be interpreted as laboratory contamination. However, the positive culture rate of our 
grafts is higher than the positive culture rate considered as contamination in our 
laboratory (less than 5%). Thus, positive cultures could be caused by non-detected 
contamination at harvesting, storing or during manipulation before implantation. Davis 
et al. [6] found similar contamination rates to us in samples taken from the sucker tips, 
light handles, blades and needles used in 100 elective primary hip and knee 
arthroplasties. Organisms found were similar to those in our study (skin commensals) 
and the rate of infection was 1% (with the infecting organism different from the single 
identified contaminant) [6]. 
 
The lack of clinical signs of infection during the follow-up of our patients may indicate 
that no specific treatment – other than our antibiotic protocol – is necessary when facing 
a case of positive culture of a graft piece after implantation. Prophylactic antibiotics and 
the patient’s immune system are enough to avoid infection. Therefore, in our opinion, 
no other special antibiotic preventive therapy or surgical treatment is required in most 
patients. 
 
We must look carefully to the microorganism involved and the antibiogram in order that 
where very pathogenic bacteria (such as Clostridium) are found the allograft is removed 
and appropriate antibiotics used. It is therefore important to obtain cultures before and 
after processing the allograft in order to identify any contaminant. 
 
We think that the contamination of these allografts happened while processing them for 
implantation in the operating theatre, as has already been reported with surgical needles 
and suckers [6]. In any case, as we have shown in our series, this contamination has no 
clinical relevance if antibiotic prophylaxis is used. To the best of our knowledge this is 
the first paper about this matter, and this high rate of allograft contamination is not 
known by most orthopaedic surgeons. The differences among the supposed or known 
rates of contamination at implantation may arise from the fact that cultures are not 
currently taken following protocol. That is the reason why we use prophylactic 
antibiotics but in most cases, where skin commensals are the contaminant, the 
possibility of achieving the same results with simpler preventive antibiotic therapy 
(such as the one we currently use in cases in which we do not implant allografts or when 
no positive culture is found after implantation) is now under consideration by the 
Clinical Infections Committee of our hospital. A prospective study will follow. 
 
Authors’ note. The authors realize that many of the references listed are not included in 
a major database and not readily available. However, we consider that they are 
important for this article. We will gladly provide them for interested readers. 
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 Table 1. Patients with positive cultures 
Patient Pathology Age (years) 
No. of 
allografts Bacteria Growth 
Follow-up 
(months)
1 Scoliosis 16 2 Corynebacterium spp. Important 66 
    Rhodococus equi Important  
2 Scoliosis 17 2 Staphylococci coagulase positive Poor 66 
    Staphylococci coagulase positive Poor  
3 Scoliosis 14 2 Staphylococci coagulase negative (ECN) Poor 60 
4 Scoliosis 12 2 Peptostreptococcus spp. Important 60 
5 Scoliosis 10 2 ECN Poor 42 
    ECN Poor  
6 Scoliosis 13 1 ECN Poor 42 
7 Scoliosis 16 2 Bacillus spp. Poor 42 
    Corynebacterum jeikeium Poor  
8 Scoliosis 12 3 ECN Poor 42 
    ECN Poor  
9 Arthritis 70 1 ECN Poor 30 
10 Scoliosis 14 1 ECN Poor 30 
11 Scoliosis 17 3 Corynebacterium jeikeium Poor 30 
12 Arthritis 54 1 Pseudomonas stutzeri Poor 30 
13 Spinal fracture 45 2 Pseudomonas stutzeri Poor 30 
14 Scoliosis 14 2 ECN Poor 18 
15 Arthritis 50 2 ECN Poor 12 
16 Arthritis 45 2 Streptococcus mitis Poor  
    Actinomyces odontolyticus Poor 18 
 
 
 
 
 
